Chang CY - Search Results

1

Review article: drug hepatotoxicity.

Chang CY, Schiano TD. Chang CY, et al. Aliment Pharmacol Ther. 2007 May 15;25(10):1135-51. doi: 10.1111/j.1365-2036.2007.03307.x. Aliment Pharmacol Ther. 2007. PMID: 17451560 Free article. Review.

2

Acetaminophen hepatotoxicity: current management.

Tan HH, Chang CY, Martin P. Tan HH, et al. Among authors: chang cy. Mt Sinai J Med. 2009 Feb;76(1):75-83. doi: 10.1002/msj.20065. Mt Sinai J Med. 2009. PMID: 19170221 No abstract available.

3

Patient with hepatitis B and alcoholic liver disease before and after liver transplantation.

Ward SC, Chang CY, Peng L, Liu LU. Ward SC, et al. Among authors: chang cy. Semin Liver Dis. 2009 May;29(2):233-7. doi: 10.1055/s-0029-1216299. Epub 2009 Apr 22. Semin Liver Dis. 2009. PMID: 19387922

4

Drug-induced steatohepatitis leading to cirrhosis: long-term toxicity of amiodarone use.

Raja K, Thung SN, Fiel MI, Chang C. Raja K, et al. Semin Liver Dis. 2009 Nov;29(4):423-8. doi: 10.1055/s-0029-1240011. Epub 2009 Oct 13. Semin Liver Dis. 2009. PMID: 19826976

5

Molecular approaches to treatment of hepatocellular carcinoma.

Lachenmayer A, Alsinet C, Chang CY, Llovet JM. Lachenmayer A, et al. Among authors: chang cy. Dig Liver Dis. 2010 Jul;42 Suppl 3(0 3):S264-72. doi: 10.1016/S1590-8658(10)60515-4. Dig Liver Dis. 2010. PMID: 20547313 Free PMC article. Review.

6

A patient with chronic hepatitis B and regression of fibrosis during treatment.

Chang CY, Martin P, Fotiadu A, Hytiroglou P. Chang CY, et al. Semin Liver Dis. 2010 Aug;30(3):296-301. doi: 10.1055/s-0030-1262515. Epub 2010 Jul 21. Semin Liver Dis. 2010. PMID: 20665381

7

Utility of the low-accelerating-dose regimen in 182 liver recipients with recurrent hepatitis C virus.

Lim KB, Sima HR, Fiel MI, Khaitova V, Doucette JT, Chernyiak M, Ahmad J, Bach N, Chang C, Grewal P, Kim-Schluger L, Liu L, Odin J, Perumalswami P, Florman SS, Schiano TD. Lim KB, et al. World J Gastroenterol. 2015 May 28;21(20):6236-45. doi: 10.3748/wjg.v21.i20.6236. World J Gastroenterol. 2015. PMID: 26034358 Free PMC article.

8

Hepatic decompensation/serious adverse events in post-liver transplantation recipients on sofosbuvir for recurrent hepatitis C virus.

Patel N, Bichoupan K, Ku L, Yalamanchili R, Harty A, Gardenier D, Ng M, Motamed D, Khaitova V, Bach N, Chang C, Grewal P, Bansal M, Agarwal R, Liu L, Im G, Leong J, Kim-Schluger L, Odin J, Ahmad J, Friedman S, Dieterich D, Schiano T, Perumalswami P, Branch A. Patel N, et al. World J Gastroenterol. 2016 Mar 7;22(9):2844-54. doi: 10.3748/wjg.v22.i9.2844. World J Gastroenterol. 2016. PMID: 26973423 Free PMC article.

9

Effectiveness and tolerability of simeprevir and sofosbuvir in nontransplant and post-liver transplant patients with hepatitis C genotype 1.

Lutchman G, Nguyen NH, Chang CY, Ahmed A, Daugherty T, Garcia G, Kumari R, Gupta S, Doshi D, Nguyen MH. Lutchman G, et al. Among authors: chang cy. Aliment Pharmacol Ther. 2016 Oct;44(7):738-46. doi: 10.1111/apt.13761. Epub 2016 Aug 10. Aliment Pharmacol Ther. 2016. PMID: 27506182 Free article.

10

Ethnic disparities in progression to advanced liver disease and overall survival in patients with chronic hepatitis C: impact of a sustained virological response.

Le AK, Zhao C, Hoang JK, Tran SA, Chang CY, Jin M, Nguyen NH, Yasukawa LA, Zhang JQ, Weber SC, Garcia G, Nguyen MH. Le AK, et al. Among authors: chang cy. Aliment Pharmacol Ther. 2017 Sep;46(6):605-616. doi: 10.1111/apt.14241. Epub 2017 Aug 2. Aliment Pharmacol Ther. 2017. PMID: 28766727

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results